Hippocampal atrophy is a key pathologic and MRI feature of human Alzheimer's disease (AD).
hippocampal volumes and total brain volumes from the MRI studies of 42 aging dogs (> 9 48 years): 16 dogs diagnosed with CCD and 26 successfully aging controls. Total hippocampal 49 volume normalized to total brain volume was significantly less for CCD patients compared with 50 control dogs (p=0.04). The results of this study suggest that-similar to human AD-hippocampal 51 atrophy is a pathological feature of CCD. This finding has potential importance for both 52 investigating disease mechanisms related to dementia as well as future hippocampal-targeted 53 therapies.
Introduction 63 Alzheimer's disease, a degenerative brain disorder of people, shares many clinical and 64 pathological features with canine cognitive dysfunction (CCD), a disorder affecting aging dogs. 65 Consequently, investigators consider CCD a naturally occurring model for studying human 66 Alzheimer's disease. Furthermore, CCD commonly causes frustration for dog owners and 67 veterinarians. 1, 2 Studies have documented hippocampal damage as an early and prominent 68 pathologic feature in both Alzheimer's disease and CCD and attributed this pathology to the 69 deposition of neurotoxic compounds such as beta-amyloid and tau proteins. 3-5
70
In humans, volumetric measurement of the hippocampi from magnetic resonance images (MRI) 71 allows clinicians to assess the presence or absence of hippocampal atrophy, as a diagnostic 72 marker for Alzheimer's disease. 6-8 Additionally, MRI-based hippocampal volumetric 73 measurements are being evaluated as means of assessing responses to future hippocampal-based 74 treatment options for Alzheimer's disease. 8,9 75 The use of MRI to assess hippocampal volume in dogs with CCD has not been reported. The 76 purpose of this MR imaging study was to compare total hippocampal volumes between dogs 77 with CCD and similarly aged control dogs. We hypothesized that dogs with CCD would have 78 smaller total hippocampal volumes compared with controls. neurologically normal small-breed dogs whose owners volunteered for a no-cost brain MRI prior 94 to scheduled dentistry procedures. Because of the nature of this study, the need for IACUC 95 approval was waived by Cornell University's Institute for Animal Care and Use Committee. 96 We based our diagnosis of CCD on previously established historical and clinical criteria together 97 with characteristic MRI abnormalities (excluding hippocampal measurements). 1, 10, 11 In addition, 98 we only included cases of CCD for which this diagnosis was clearly stated in the medical record 99 and supported by the MRI report. For each dog, three-dimensional volumes were measured from T2-weighted brain images using 111 Mimics ® software by two observers (JS and MO) who were unaware of the status of the dogs in 112 the study. Quantitative volumetric measurements of both hippocampi as well as total brain 113 volume were acquired for each dog, as previously described ( Figure 1 ). 12 Anatomic landmarks 114 for measurements were used from published reference information. 13,14
115
We then normalized total hippocampal volumes to total brain volume (rather than bodyweight) 116 under the assumption that total brain volume would not change with CCD, and that total brain Because hippocampal volume represents a small percentage of total brain volume, we multiplied 120 the volume ratio by 1000 to have more easily understood values.
121

Statistical Analyses
122
We compared all continuous variables (i.e. normalized hippocampal volumes, age) between the 123 CCD dogs and control dogs using Mann Whitney U Tests.
124
To assess for both intra and inter-observer variability in measurements, 20 patient scans were Our study demonstrates that dogs afflicted with CCD have smaller hippocampal volumes 154 compared to similarly aged control dogs without CCD. The differences were small, and showed 155 a substantial degree of overlap between the two groups, suggesting that hippocampal volumetric 156 measurements in dogs will be unable to discriminate between healthy and CCD dogs on an 157 individual basis. However, our data suggest that hippocampal atrophy is not part of canine in CCD patients may potentially benefit dogs with that disorder and human Alzheimer's disease 170 patients.
171
There are several limitations to this study, most of which are related to its retrospective nature.
172
Although multiple institutions were involved in recruiting case material, the case numbers are 9 173 still small. Also, the MR images evaluated were derived from multiple different machines, which 174 could introduce some level of variability in the resultant data. We restricted case enrollment to 175 dogs 9 yrs and older, in accordance with previous publications dealing with aging dogs. 10,23,24
176
Although the median ages of our CCD and control groups was not large (11.5 yrs vs 13 yrs), it dogs. 23, 24 In one study, linear MRI measurements of the hippocampi normalized to brain height 188 were compared between young (1-3 year old) and older (>10 year old) dogs with normal brain 189 anatomy; a significant reduction of 2.64% was found between young and old dogs in that 190 study. 23 should be performed. Hopefully, investigations into hippocampal-related aspects of Alzheimer's 205 disease will benefit from CCD dogs as a disease model.
206
In conclusion, we demonstrated that dogs with CCD have significantly smaller total hippocampal 
